IP Library Granted Patent US 8,741,814
Granted Patent B2
US 8,741,814 · App. 12/603,255 · Granted Jun 3, 2014

T cell receptor display

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,741,814
App. No.
12/603,255
Granted
Jun 3, 2014
Kind
B2
Abstract

A proteinaceous particle, for example a bacteriophage, ribosome or cell, displaying on its surface a T-cell receptor (TCR). The displayed TCR is preferably a heterodimer having a non-native disulfide bond between constant domain residues. Such display particles may be used for the creation of diverse TCR libraries for the identification of high affinity TCRs. Several high affinities are disclosed.

Claims (17)

1. A phage particle displaying on its surface a human dimeric T cell receptor (TCR) polypeptide pair constituted by:

a TCR α chain variable domain sequence fused to the N terminus of a TCR α chain constant domain extracellular sequence; and

a TCR β chain variable domain sequence fused to the N terminus of a TCR β chain constant domain extracellular sequence,

wherein the TCR α chain constant domain extracellular sequence and the TCR β chain constant domain extracellular sequence are linked by a disulfide bond between cysteine residues substituted for:

Thr 48 of exon 1 of TRAC*01 at position 10 with reference to the position numbering of SEQ ID NO: 1 and Ser 57 of exon 1 of TRBC1 *01 or TRBC2*01 at position 10 with reference to the position numbering of SEQ ID NO: 5;

Thr 45 of exon 1 of TRAC*01 at position 10 with reference to the position numbering of SEQ ID NO: 2 and Ser 77 of exon 1 of TRBC1 *01 or TRBC2*01 at position 10 with reference to the position numbering of SEQ ID NO: 6;

Tyr 10 of exon 1 of TRAC*01 at position 10 with reference to the position numbering of SEQ ID NO: 3 and Ser 17 of exon 1 of TRBC1 *01 or TRBC2*01 at position 10 with reference to the position numbering of SEQ ID NO: 7;

Thr 45 of exon 1 of TRAC*01 at position 10 with reference to the position numbering of SEQ ID NO: 2 and Asp 59 of exon 1 of TRBC1 *01 or TRBC2*01 at position 10 with reference to the position numbering of SEQ ID NO: 8; or

Ser 15 of exon 1 of TRAC*01 at position 10 with reference to the position numbering of SEQ ID NO: 4 and Glu 15 of exon 1 of TRBC1 *01 or TRBC2*01 at position 10 with reference to the position numbering of SEQ ID NO: 9.

2. The phage particle of claim 1 which is a filamentous phage particle.

3. The phage particle of claim 1 wherein the C terminus of the TCR α chain constant domain extracellular sequence or the C terminus of the TCR β chain constant domain extracellular sequence is linked by a peptide bond to a coat protein of the phage particle.

4. The phage particle of claim 1 wherein the TCR α chain constant domain extracellular sequence and the TCR β chain constant domain extracellular sequence are truncated to exclude cysteine residues which form a disulfide bond in a native TCR.

5. The phage particle of claim 1 wherein cysteine residues in the TCR α chain constant domain extracellular sequence and the TCR β chain constant domain extracellular sequence which form a disulfide bond in a native TCR are substituted by a different amino acid residue.

6. A filamentous phage particle displaying on its surface a human dimeric T cell receptor (TCR) polypeptide pair constituted by:

a TCR α chain variable domain sequence fused to the N terminus of a TCR α chain constant domain extracellular sequence; and

a TCR β chain variable domain sequence fused to the N terminus of a TCR β chain constant domain extracellular sequence,

wherein the TCR α chain constant domain extracellular sequence and the TCR β chain constant domain extracellular sequence are linked by a disulfide bond between cysteine residues substituted for Thr 48 of exon 1 of TRAC*01 at position 10 with reference to the position numbering of SEQ ID NO: 1 and Ser 57 of exon 1 of TRBC1 *01 or TRBC2*01 at position 10 with reference to the position numbering of SEQ ID NO: 5, and wherein the C terminus of the TCR α chain constant domain extracellular sequence or the C terminus of the TCR β chain constant domain extracellular sequence is linked by a peptide bond to a coat protein of the phage particle.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2022
From: OXFORD FINANCE LUXEMBOURG S.À R.L
To: IMMUNOCORE LIMITED; IMMUNOCORE LLC; IMMUNOCORE COMMERCIAL LLC
Reel/Frame 061916/0493 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE PREVIOUSLY RECORDED AT REEL: 030824 FRAME: 0150. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 10, 2020
From: IMMUNOCORE LIMITED
To: IMMUNOCORE LIMITED; ADAPTIMMUNE LIMITED
Reel/Frame 054373/0041 →
SECURITY INTEREST Recorded Nov 6, 2020
From: IMMUNOCORE LIMITED; IMMUNOCORE LLC; IMMUNOCORE COMMERCIAL LLC
To: OXFORD FINANCE LUXEMBOURG S.À R.L., REGISTERED WITH THE LUXEMBOURG COMMERCIAL REGISTER UNDER NUMBER B243395, ACTING IN RESPECT OF ITS COMPARTMENT 1
Reel/Frame 054344/0218 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2013
From: IMMUNOCORE LIMITED
To: ADAPTIMMUNE LIMITED; IMMUNOCORE LIMITED
Reel/Frame 030824/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2012
From: JAKOBSEN, BENT KARSTEN; ANDERSEN, TORBEN BENT; MOLLOY, PETER EAMON; LI, YI; BOULTER, JONATHAN MICHAEL
To: AVIDEX LIMITED
Reel/Frame 027915/0576 →
CHANGE OF NAME Recorded Mar 23, 2012
From: AVIDEX LIMITED
To: MEDIGENE LIMITED
Reel/Frame 027915/0667 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2012
From: MEDIGENE LIMITED
To: IMMUNOCORE LIMITED
Reel/Frame 027915/0868 →